Cargando…
Does chemotherapy-induced neutropaenia result in a postponement of adjuvant or neoadjuvant regimens in breast cancer patients? Results of a retrospective analysis
In 2005, 224 patients received adjuvant/neoadjuvant chemotherapy for breast cancer in a single institution according to daily practices. Regimens consisted of epirubicin-based chemotherapy (FEC100, four or six cycles), or three cycles of FEC100 followed by three cycles of docetaxel. An absolute bloo...
Autores principales: | Debled, M, Houédé, N, Madranges, N, Donamaria, C, Floquet, A, Durand, M, Mauriac, Louis |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360274/ https://www.ncbi.nlm.nih.gov/pubmed/18000502 http://dx.doi.org/10.1038/sj.bjc.6604094 |
Ejemplares similares
-
Use of granulocyte colony-stimulating factor in patients with chemotherapy-induced neutropaenia
por: Shokane, Lucky L., et al.
Publicado: (2023) -
Systemic lupus erythematosus and neutropaenia: a hallmark of haematological manifestations
por: Meyer, Aurore, et al.
Publicado: (2020) -
Does chemotherapy regimen matter in the neoadjuvant treatment of esophageal cancer?
por: Logarajah, Shankar, et al.
Publicado: (2022) -
A case of chronic disseminated candidiasis in metamizole-induced neutropaenia
por: Colin-Benoit, Eugénie, et al.
Publicado: (2022) -
Mannose-Binding Lectin 2 Polymorphisms Do Not Influence Frequency or Type of Infection in Adults with Chemotherapy Induced Neutropaenia
por: Wong, Michelle, et al.
Publicado: (2012)